Crinetics PharmaceuticalsNASDAQ: CRNX: Develops oral therapies for rare endocrine-related diseases.
5+ YOEBachelor's degree, 5+ years IDN/key account or 8+ years rare disease pharma sales, deep knowledge of U.S. healthcare systems and formulary access, experience with Kaiser Permanente or similar IDNs, valid U.S. driver’s license.